BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation

Xuxia Gao, Yanna Cao, Wenli Yang, Chaojun Duan, Judith Aronson, Cristiana Rastellini, Celia Chao, Mark Hellmich, Tien C. Ko

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Activation of pancreatic stellate cells (PSCs) by transforming growth factor (TGF)-β is the key step in the development of pancreatic fibrosis, a common pathological feature of chronic pancreatitis (CP). Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, have anti-fibrogenic functions, in contrast to TGF-β, in the kidney, lung, and liver. However, it is not known whether BMPs have an anti-fibrogenic role in the pancreas. The current study was designed to investigate the potential anti-fibrogenic role of BMPs in the pancreas using an in vivo CP model and an in vitro PSC model. CP was induced by repetitive intraperitoneal injections of cerulein in adult Swiss Webster mice. The control mice received saline injections. Compared with the control, cerulein injections induced a time-dependent increase in acinar injury and progression of fibrosis and a steady increase in inflammation. Cerulein injections also induced increases of the extracellular matrix (ECM) protein fibronectin and of α-smooth muscle actin (α-SMA)-positive stellate cells (PSCs). The mice receiving cerulein injections showed increased BMP2 protein levels and phosphorylated Smad1 levels up to 4 wk and then declined at 8 wk to similar levels as the control. In vitro, the isolated mouse and human PSCs were cultured and pretreated with BMP2 followed by TGF-β treatment. BMP2 pretreatment inhibited TGF-β-induced α-SMA, fibronectin, and collagen type Ia expression. Knocking down Smad1 with small-interfering RNA reversed the inhibitory effect of BMP2 on TGF-β-induced α-SMA and fibronectin expression. Thus, BMP2 opposes the fibrogenic function of TGF-β in PSCs through the Smad1 signaling pathway.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume304
Issue number9
DOIs
StatePublished - 2013

Fingerprint

Pancreatic Stellate Cells
Transforming Growth Factors
Extracellular Matrix
Ceruletide
Bone Morphogenetic Proteins
Chronic Pancreatitis
Fibronectins
Injections
Pancreas
Fibrosis
Extracellular Matrix Proteins
Intraperitoneal Injections
Small Interfering RNA
Smooth Muscle
Actins
Collagen
Inflammation
Kidney
Lung
Liver

Keywords

  • Bone morphogenetic protein
  • Pancreas stellate cell
  • Pancreatic fibrosis
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology (medical)
  • Physiology
  • Hepatology

Cite this

BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation. / Gao, Xuxia; Cao, Yanna; Yang, Wenli; Duan, Chaojun; Aronson, Judith; Rastellini, Cristiana; Chao, Celia; Hellmich, Mark; Ko, Tien C.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 304, No. 9, 2013.

Research output: Contribution to journalArticle

@article{886ef1c2ff874026916fcd64224c77e4,
title = "BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation",
abstract = "Activation of pancreatic stellate cells (PSCs) by transforming growth factor (TGF)-β is the key step in the development of pancreatic fibrosis, a common pathological feature of chronic pancreatitis (CP). Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, have anti-fibrogenic functions, in contrast to TGF-β, in the kidney, lung, and liver. However, it is not known whether BMPs have an anti-fibrogenic role in the pancreas. The current study was designed to investigate the potential anti-fibrogenic role of BMPs in the pancreas using an in vivo CP model and an in vitro PSC model. CP was induced by repetitive intraperitoneal injections of cerulein in adult Swiss Webster mice. The control mice received saline injections. Compared with the control, cerulein injections induced a time-dependent increase in acinar injury and progression of fibrosis and a steady increase in inflammation. Cerulein injections also induced increases of the extracellular matrix (ECM) protein fibronectin and of α-smooth muscle actin (α-SMA)-positive stellate cells (PSCs). The mice receiving cerulein injections showed increased BMP2 protein levels and phosphorylated Smad1 levels up to 4 wk and then declined at 8 wk to similar levels as the control. In vitro, the isolated mouse and human PSCs were cultured and pretreated with BMP2 followed by TGF-β treatment. BMP2 pretreatment inhibited TGF-β-induced α-SMA, fibronectin, and collagen type Ia expression. Knocking down Smad1 with small-interfering RNA reversed the inhibitory effect of BMP2 on TGF-β-induced α-SMA and fibronectin expression. Thus, BMP2 opposes the fibrogenic function of TGF-β in PSCs through the Smad1 signaling pathway.",
keywords = "Bone morphogenetic protein, Pancreas stellate cell, Pancreatic fibrosis, Transforming growth factor-β",
author = "Xuxia Gao and Yanna Cao and Wenli Yang and Chaojun Duan and Judith Aronson and Cristiana Rastellini and Celia Chao and Mark Hellmich and Ko, {Tien C.}",
year = "2013",
doi = "10.1152/ajpgi.00306.2012",
language = "English (US)",
volume = "304",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "9",

}

TY - JOUR

T1 - BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation

AU - Gao, Xuxia

AU - Cao, Yanna

AU - Yang, Wenli

AU - Duan, Chaojun

AU - Aronson, Judith

AU - Rastellini, Cristiana

AU - Chao, Celia

AU - Hellmich, Mark

AU - Ko, Tien C.

PY - 2013

Y1 - 2013

N2 - Activation of pancreatic stellate cells (PSCs) by transforming growth factor (TGF)-β is the key step in the development of pancreatic fibrosis, a common pathological feature of chronic pancreatitis (CP). Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, have anti-fibrogenic functions, in contrast to TGF-β, in the kidney, lung, and liver. However, it is not known whether BMPs have an anti-fibrogenic role in the pancreas. The current study was designed to investigate the potential anti-fibrogenic role of BMPs in the pancreas using an in vivo CP model and an in vitro PSC model. CP was induced by repetitive intraperitoneal injections of cerulein in adult Swiss Webster mice. The control mice received saline injections. Compared with the control, cerulein injections induced a time-dependent increase in acinar injury and progression of fibrosis and a steady increase in inflammation. Cerulein injections also induced increases of the extracellular matrix (ECM) protein fibronectin and of α-smooth muscle actin (α-SMA)-positive stellate cells (PSCs). The mice receiving cerulein injections showed increased BMP2 protein levels and phosphorylated Smad1 levels up to 4 wk and then declined at 8 wk to similar levels as the control. In vitro, the isolated mouse and human PSCs were cultured and pretreated with BMP2 followed by TGF-β treatment. BMP2 pretreatment inhibited TGF-β-induced α-SMA, fibronectin, and collagen type Ia expression. Knocking down Smad1 with small-interfering RNA reversed the inhibitory effect of BMP2 on TGF-β-induced α-SMA and fibronectin expression. Thus, BMP2 opposes the fibrogenic function of TGF-β in PSCs through the Smad1 signaling pathway.

AB - Activation of pancreatic stellate cells (PSCs) by transforming growth factor (TGF)-β is the key step in the development of pancreatic fibrosis, a common pathological feature of chronic pancreatitis (CP). Bone morphogenetic proteins (BMPs), members of the TGF-β superfamily, have anti-fibrogenic functions, in contrast to TGF-β, in the kidney, lung, and liver. However, it is not known whether BMPs have an anti-fibrogenic role in the pancreas. The current study was designed to investigate the potential anti-fibrogenic role of BMPs in the pancreas using an in vivo CP model and an in vitro PSC model. CP was induced by repetitive intraperitoneal injections of cerulein in adult Swiss Webster mice. The control mice received saline injections. Compared with the control, cerulein injections induced a time-dependent increase in acinar injury and progression of fibrosis and a steady increase in inflammation. Cerulein injections also induced increases of the extracellular matrix (ECM) protein fibronectin and of α-smooth muscle actin (α-SMA)-positive stellate cells (PSCs). The mice receiving cerulein injections showed increased BMP2 protein levels and phosphorylated Smad1 levels up to 4 wk and then declined at 8 wk to similar levels as the control. In vitro, the isolated mouse and human PSCs were cultured and pretreated with BMP2 followed by TGF-β treatment. BMP2 pretreatment inhibited TGF-β-induced α-SMA, fibronectin, and collagen type Ia expression. Knocking down Smad1 with small-interfering RNA reversed the inhibitory effect of BMP2 on TGF-β-induced α-SMA and fibronectin expression. Thus, BMP2 opposes the fibrogenic function of TGF-β in PSCs through the Smad1 signaling pathway.

KW - Bone morphogenetic protein

KW - Pancreas stellate cell

KW - Pancreatic fibrosis

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=84878536199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878536199&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00306.2012

DO - 10.1152/ajpgi.00306.2012

M3 - Article

C2 - 23429583

AN - SCOPUS:84878536199

VL - 304

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 9

ER -